Clinical Evaluation of Medicated Bathing Agent Eaudeleman in Patients with Atopic Dermatitis:Clinical Research Group of Medicated Bathing Agent Eaudeleman

Tetsuro Sugai; Junko Katoh; Toshio Hamada; Kazunobu Mochida; Hirokazu Yasuno; Kiyoshi Kagami; Ritsuko Hayakawa; Mari Suzuki; Yasuko Ogino; Hiroshi Ueda; Kayoko Matsunaga

doi:10.11340/skinresearch1959.36.867

Clinical Evaluation of Medicated Bathing Agent Eaudeleman in Patients with Atopic Dermatitis:Clinical Research Group of Medicated Bathing Agent Eaudeleman

Tetsuro Sugai, Junko Katoh, Toshio Hamada, Kazunobu Mochida, Hirokazu Yasuno, Kiyoshi Kagami, Ritsuko Hayakawa, Mari Suzuki, Yasuko Ogino, Hiroshi Ueda, Kayoko Matsunaga

integrative medical science for allergic disease

Research output: Contribution to journal › Article › peer-review

Abstract

Clinical evaluation of medicated bathing agent “Eaudeleman” is made in 67 patients with atopic dermatitis and 26 patients with asteatotic dermatitis for 4 weeks in a multicenter open trial study. In addition, 59 patients with atopic dermatitis and 25 patients with asteatotic dermatitis are also evaluated as a control group. No significant difference was found between the test group and the control group in the both diseases. The final global improvement rating was 65.7% (44/67) at the test group and 71.2% (43/59) at the control group in more than slight improvement in atopic patients, while it was 100.0% (26/26) at the test group and 88.0% (22/25) at the control group in asteatotic patients. The side effects were seen seven in patients with atopic dermatitis, and none in patients with asteatotic dermatitis.

Original language	English
Pages (from-to)	867-874
Number of pages	8
Journal	skin research
Volume	36
Issue number	6
DOIs	https://doi.org/10.11340/skinresearch1959.36.867
Publication status	Published - 1994

All Science Journal Classification (ASJC) codes

Dermatology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.11340/skinresearch1959.36.867

Cite this

Sugai, T., Katoh, J., Hamada, T., Mochida, K., Yasuno, H., Kagami, K., Hayakawa, R., Suzuki, M., Ogino, Y., Ueda, H., & Matsunaga, K. (1994). Clinical Evaluation of Medicated Bathing Agent Eaudeleman in Patients with Atopic Dermatitis:Clinical Research Group of Medicated Bathing Agent Eaudeleman. skin research, 36(6), 867-874. https://doi.org/10.11340/skinresearch1959.36.867

@article{6cda0b78330d42e6915a3113acd26c29,

title = "Clinical Evaluation of Medicated Bathing Agent Eaudeleman in Patients with Atopic Dermatitis:Clinical Research Group of Medicated Bathing Agent Eaudeleman",

abstract = "Clinical evaluation of medicated bathing agent “Eaudeleman” is made in 67 patients with atopic dermatitis and 26 patients with asteatotic dermatitis for 4 weeks in a multicenter open trial study. In addition, 59 patients with atopic dermatitis and 25 patients with asteatotic dermatitis are also evaluated as a control group. No significant difference was found between the test group and the control group in the both diseases. The final global improvement rating was 65.7% (44/67) at the test group and 71.2% (43/59) at the control group in more than slight improvement in atopic patients, while it was 100.0% (26/26) at the test group and 88.0% (22/25) at the control group in asteatotic patients. The side effects were seen seven in patients with atopic dermatitis, and none in patients with asteatotic dermatitis.",

author = "Tetsuro Sugai and Junko Katoh and Toshio Hamada and Kazunobu Mochida and Hirokazu Yasuno and Kiyoshi Kagami and Ritsuko Hayakawa and Mari Suzuki and Yasuko Ogino and Hiroshi Ueda and Kayoko Matsunaga",

year = "1994",

doi = "10.11340/skinresearch1959.36.867",

language = "English",

volume = "36",

pages = "867--874",

journal = "skin research",

issn = "0018-1390",

publisher = "Osaka University Medical School",

number = "6",

}

Sugai, T, Katoh, J, Hamada, T, Mochida, K, Yasuno, H, Kagami, K, Hayakawa, R, Suzuki, M, Ogino, Y, Ueda, H & Matsunaga, K 1994, 'Clinical Evaluation of Medicated Bathing Agent Eaudeleman in Patients with Atopic Dermatitis:Clinical Research Group of Medicated Bathing Agent Eaudeleman', skin research, vol. 36, no. 6, pp. 867-874. https://doi.org/10.11340/skinresearch1959.36.867

TY - JOUR

T1 - Clinical Evaluation of Medicated Bathing Agent Eaudeleman in Patients with Atopic Dermatitis:Clinical Research Group of Medicated Bathing Agent Eaudeleman

AU - Sugai, Tetsuro

AU - Katoh, Junko

AU - Hamada, Toshio

AU - Mochida, Kazunobu

AU - Yasuno, Hirokazu

AU - Kagami, Kiyoshi

AU - Hayakawa, Ritsuko

AU - Suzuki, Mari

AU - Ogino, Yasuko

AU - Ueda, Hiroshi

AU - Matsunaga, Kayoko

PY - 1994

Y1 - 1994

N2 - Clinical evaluation of medicated bathing agent “Eaudeleman” is made in 67 patients with atopic dermatitis and 26 patients with asteatotic dermatitis for 4 weeks in a multicenter open trial study. In addition, 59 patients with atopic dermatitis and 25 patients with asteatotic dermatitis are also evaluated as a control group. No significant difference was found between the test group and the control group in the both diseases. The final global improvement rating was 65.7% (44/67) at the test group and 71.2% (43/59) at the control group in more than slight improvement in atopic patients, while it was 100.0% (26/26) at the test group and 88.0% (22/25) at the control group in asteatotic patients. The side effects were seen seven in patients with atopic dermatitis, and none in patients with asteatotic dermatitis.

AB - Clinical evaluation of medicated bathing agent “Eaudeleman” is made in 67 patients with atopic dermatitis and 26 patients with asteatotic dermatitis for 4 weeks in a multicenter open trial study. In addition, 59 patients with atopic dermatitis and 25 patients with asteatotic dermatitis are also evaluated as a control group. No significant difference was found between the test group and the control group in the both diseases. The final global improvement rating was 65.7% (44/67) at the test group and 71.2% (43/59) at the control group in more than slight improvement in atopic patients, while it was 100.0% (26/26) at the test group and 88.0% (22/25) at the control group in asteatotic patients. The side effects were seen seven in patients with atopic dermatitis, and none in patients with asteatotic dermatitis.

UR - http://www.scopus.com/inward/record.url?scp=0028591793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028591793&partnerID=8YFLogxK

U2 - 10.11340/skinresearch1959.36.867

DO - 10.11340/skinresearch1959.36.867

M3 - Article

AN - SCOPUS:0028591793

SN - 0018-1390

VL - 36

SP - 867

EP - 874

JO - skin research

JF - skin research

IS - 6

ER -

Clinical Evaluation of Medicated Bathing Agent Eaudeleman in Patients with Atopic Dermatitis:Clinical Research Group of Medicated Bathing Agent Eaudeleman

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this